What Does Simcere Pharmaceutical Group Do?

Total employees7558
HeadquartersNanjing
Founded1995

Simcere Pharmaceutical Group Ltd. is an innovation and R&D-driven pharmaceutical company with a mission of 'providing today's patients with medicines of the future.' It focuses on therapeutic areas with significant unmet clinical needs, including oncology, central nervous system diseases, and autoimmune diseases. Simcere has established a strong presence in China and is expanding globally, leveraging its robust R&D capabilities, manufacturing excellence, and commercial network. The company is committed to developing and delivering high-quality, innovative medicines to improve patient health and quality of life.

Where Is Simcere Pharmaceutical Group's Headquarters?

Simcere Pharmaceutical Group officeSimcere Pharmaceutical Group officeSimcere Pharmaceutical Group officeSimcere Pharmaceutical Group office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for strategic decision-making, corporate management, research and development leadership, and coordination of global operations.

Notable Features:

Features state-of-the-art R&D laboratories, modern office spaces, and GMP-certified manufacturing facilities, reflecting its focus on innovation and pharmaceutical production.

Work Culture:

Emphasizes innovation, collaboration, scientific rigor, and a patient-centric approach. Fosters a dynamic environment for research and development talent.

HQ Significance:

Central to Simcere's operations, driving its R&D pipeline, strategic partnerships, and market expansion efforts both domestically in China and internationally.

Values Reflected in HQ: The headquarters reflects Simcere's commitment to innovation, quality, scientific excellence, and its core mission to develop and deliver better medicines for patients.

Location:

Simcere Pharmaceutical Group primarily operates in China with comprehensive R&D, manufacturing, and commercial activities. It is actively expanding its global footprint through R&D centers and business development offices in the United States (e.g., Boston, Maryland) and strategic collaborations with international partners. These global functions support drug discovery, translational research, clinical development, and licensing activities, aiming to bring innovative medicines developed in China to the world, and source global innovations for the Chinese market.

Street Address:

Building A1, No. 699-18 Xuanwu Avenue, Xuanwu District

City:

Nanjing

State/Province:

Jiangsu

Country:

China

Where Else Does Simcere Pharmaceutical Group Operate Around the World?

Shanghai, China

Address: Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China (Simcere (Shanghai) R&D Co., Ltd.)

To tap into Shanghai's rich talent pool and collaborative opportunities in biotechnology and pharmaceutical research, advancing key therapeutic programs.

Cambridge, Massachusetts, USA

Address: One Broadway, 14th Floor, Cambridge, MA 02142, USA (Simcere Innovation Inc.)

To access cutting-edge research, talent, and partnership opportunities within the leading Boston/Cambridge biotech hub, fostering global drug development initiatives.

Beijing, China

Address: Key business districts, Beijing, China (e.g., Chaoyang District)

To manage clinical trials effectively, engage with national regulatory bodies like the NMPA, and support commercial operations in Northern China.

Buying Intent Signals for Simcere Pharmaceutical Group

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Simcere Pharmaceutical Group? Meet the Executive Team

As of April 2025, Simcere Pharmaceutical Group' leadership includes:

Ren Jinsheng - Chairman and Chief Executive Officer
Dr. Zhou Gaobo - Executive Director and Chief Scientific Officer
Wan Yuqing - Executive Director and Senior Vice President
Ms. Chen Pingping - Chief Financial Officer
Frank Zhang - Chief Strategy Officer

Who's Investing in Simcere Pharmaceutical Group?

Simcere Pharmaceutical Group has been backed by several prominent investors over the years, including:

Hillhouse Capital
Boyu Capital
Temasek Holdings
Gaoling Fund, L.P.

What Leadership Changes Has Simcere Pharmaceutical Group Seen Recently?

Hire1
Exits1

Simcere Pharmaceutical Group saw a key transition in its financial leadership over the last 12 months with the departure of its CFO and the appointment of a new CFO to steer its financial strategy.

Departures

Tang Renhong, Mr. Tang Renhong resigned from his positions as Executive Director and Chief Financial Officer due to personal career development.

New Appointments:

Chen Pingping, Ms. Chen Pingping appointed as Chief Financial Officer, bringing extensive financial management experience to the company.

What Technology (Tech Stack) Is Used bySimcere Pharmaceutical Group?

Discover the tools Simcere Pharmaceutical Group uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Simcere Pharmaceutical Group Email Formats and Examples

Common email formats for Simcere Pharmaceutical Group likely involve combinations of employee names. For Chinese names, pinyin (Romanized spelling) is typically used. The most common patterns are often [firstinitial][lastname]@simcere.com or [firstname].[lastname]@simcere.com.

firstinitiallastname@simcere.com

Format

jdoe@simcere.com

Example

75%

Success rate

What's the Latest News About Simcere Pharmaceutical Group?

PR Newswire • April 26, 2024

Simcere Pharmaceutical Group Announces IND Approval for Its Novel SOS1 Inhibitor SCR-8554's Clinical Trial in China

Simcere Pharmaceutical Group announced that its SOS1 inhibitor (SCR-8554) for treating advanced solid tumors has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA) to initiate clinical trials....more

PR Newswire • March 27, 2024

Simcere Pharmaceutical Group Announces 2023 Annual Results: Revenue from Innovative Drugs Increased by 26.3%

Simcere reported its 2023 annual results, highlighting a 26.3% year-on-year increase in revenue from innovative drugs, reaching RMB 4.06 billion. Total revenue was RMB 6.11 billion, with R&D investment accounting for 27.8% of pharmaceutical revenue....more

PR Newswire • January 18, 2024

Simcere Pharmaceutical Group and Novoimmune Enter into a Strategic Collaboration to Develop Next-Generation Immunotherapies

Simcere Pharmaceutical Group and Novoimmune Ltd. announced a strategic collaboration to co-develop novel bi-specific and tri-specific antibodies for cancer treatment, leveraging Novoimmune's nITAb platform and Simcere's R&D and commercialization capabilities....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Simcere Pharmaceutical Group, are just a search away.